These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28541925)

  • 1. Improvement Screening for Ultra-High Dimensional Data with Censored Survival Outcomes and Varying Coefficients.
    Yue M; Li J
    Int J Biostat; 2017 May; 13(1):. PubMed ID: 28541925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.
    Uno H; Tian L; Cai T; Kohane IS; Wei LJ
    Stat Med; 2013 Jun; 32(14):2430-42. PubMed ID: 23037800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.
    Shao F; Li J; Fine J; Wong WK; Pencina M
    Biomarkers; 2015; 20(4):240-52. PubMed ID: 26301882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.
    Wang Z; Cheng Y; Seaberg EC; Becker JT
    Biostatistics; 2020 Feb; 23(2):666-82. PubMed ID: 33324980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis.
    Jung HY; Kim SH; Jang HM; Lee S; Kim YS; Kang SW; Yang CW; Kim NH; Choi JY; Cho JH; Kim CD; Park SH; Kim YL
    PLoS One; 2018; 13(3):e0193511. PubMed ID: 29494637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.
    Zheng Y; Parast L; Cai T; Brown M
    Lifetime Data Anal; 2013 Jul; 19(3):350-70. PubMed ID: 23254468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary information improves cardiovascular disease risk prediction models.
    Baik I; Cho NH; Kim SH; Shin C
    Eur J Clin Nutr; 2013 Jan; 67(1):25-30. PubMed ID: 23149979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating a New Risk Marker's Predictive Contribution in Survival Models.
    Liu M; Kapadia AS; Etzel CJ
    J Stat Theory Pract; 2010 Dec; 4(4):845-855. PubMed ID: 22984361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparse boosting for high-dimensional survival data with varying coefficients.
    Yue M; Li J; Ma S
    Stat Med; 2018 Feb; 37(5):789-800. PubMed ID: 29152776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.
    Burch PM; Glaab WE; Holder DJ; Phillips JA; Sauer JM; Walker EG
    Toxicol Sci; 2017 Mar; 156(1):11-13. PubMed ID: 27815493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical methods for assessment of added usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Vasan RS
    Clin Chem Lab Med; 2010 Dec; 48(12):1703-11. PubMed ID: 20716010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.
    Mehta HB; Mehta V; Tsai CL; Chen H; Aparasu RR; Johnson ML
    J Alzheimers Dis; 2016; 49(2):423-32. PubMed ID: 26519436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.
    Pencina MJ; D'Agostino RB; Steyerberg EW
    Stat Med; 2011 Jan; 30(1):11-21. PubMed ID: 21204120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model.
    Austin PC; Pencinca MJ; Steyerberg EW
    Stat Methods Med Res; 2017 Jun; 26(3):1053-1077. PubMed ID: 25656552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What to expect from net reclassification improvement with three categories.
    Pencina KM; Pencina MJ; D'Agostino RB
    Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.